Neonatal group B streptococcal infection. Results of 33 months of universal maternal screening and antibioprophylaxis (Q31784207)

3 July 2017

title

Neonatal group B streptococcal infection. Results of 33 months of universal maternal screening and antibioprophylaxis (English)

1 reference

3 July 2017

J L Voluménie

1

1 reference

3 July 2017

H Fernandez

2

1 reference

3 July 2017

M Vial

3

1 reference

3 July 2017

L Lebrun

4

1 reference

3 July 2017

R Frydman

5

1 reference

3 July 2017

publication date

1 January 2001

1 reference

European Journal of Obstetrics Gynecology and Reproductive Biology

3 July 2017

published in

1 reference

3 July 2017

volume

94

1 reference

3 July 2017

issue

1

1 reference

3 July 2017

page(s)

79-85

1 reference

Ampicillin Prevents Intrapartum Transmission of Group B Streptococcus

3 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900340-7

7 January 2021

Selective Intrapartum Chemoprophylaxis of Neonatal Group B Streptococcal Early-Onset Disease. I. Epidemiologic Rationale

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900340-7

7 January 2021

Group B streptococcus (GBS) and neonatal infections: the case for intrapartum chemoprophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900340-7

7 January 2021

Group B streptococci: results of a protocol of antepartum screening and intrapartum treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900340-7

7 January 2021

Neonatal group B streptococcal infection in a managed care population. Perinatal Group B Streptococcal Infection Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900340-7

7 January 2021

Selective intrapartum anti-bioprophylaxy of group B streptococci infection of neonates: a prospective study in 2454 subsequent deliveries

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900340-7

7 January 2021

Group B streptococci during pregnancy: a comparison of two screening and treatment protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900340-7

7 January 2021

Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900340-7

7 January 2021

Opportunities for prevention of perinatal group B streptococcal disease: a multistate surveillance analysis. The Neonatal Group B Streptococcal Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900340-7

7 January 2021

Prophylaxis for neonatal group B streptococcus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900340-7

7 January 2021

Compliance with the Centers for Disease Control and Prevention antenatal culture protocol for preventing group B streptococcal neonatal sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900340-7

7 January 2021

Selective Intrapartum Chemoprophylaxis of Neonatal Group B Streptococcal Early-Onset Disease. II. Predictive Value of Prenatal Cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900340-7

7 January 2021

Enhanced antenatal detection of group B streptococcus colonization

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900340-7

7 January 2021

Prevention practices for perinatal group B streptococcal disease: a multi-state surveillance analysis. Neonatal Group B Streptococcal Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900340-7

7 January 2021

Prenatal screening for group B Streptococcus. II. Impact of antepartum screening and prophylaxis on neonatal care

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900340-7

7 January 2021

10.1016/S0301-2115(00)00340-7

Identifiers

DOI

1 reference

3 July 2017

1 reference